# The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions

> **NCT01204359** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 627 (estimated)

## Conditions studied

- Hypothyroidism
- Exophthalmos

## Interventions

- **RADIATION:** Iodine 131

## Key facts

- **NCT ID:** NCT01204359
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-07
- **Primary completion:** 2016-07
- **Final completion:** 2016-12
- **Target enrollment:** 627 (ESTIMATED)
- **Last updated:** 2015-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01204359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01204359, "The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01204359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*